Variables * | B | Odds ratio | (95 % confidence interval ) | P-value |
---|---|---|---|---|
Women’ age | -0.04 | 0.95 | (0.90–1.02) | 0.16 |
Women’ body mass index | 0.05 | 1.04 | (0.89 − 0.12) | 0.55 |
Cause of infertility | ||||
Polycystic ovary syndrome | - | Reference group | - | |
Male factor | 0.32 | 1.37 | (0.76–2.50) | 0.28 |
Tubal factor | -0.49 | 0.60 | (0.22–1.65) | 0.32 |
Unexplained factor | 0.07 | 1.08 | (0.41–2.79) | 0.87 |
Mixed factor (both male and female) | − 0.32 | 0.72 | (0.24–2.17) | 0.56 |
Number of MII oocyte | 0.07 | 1.07 | (0.92–1.25) | 0.34 |
Number of transferred embryos | 0.15 | 1.16 | (0.67-2.0) | 0.57 |
Endometrial thickness on ET day | 0.09 | 1.09 | (0.90–1.31) | 0.34 |
Progesterone value quartile (Q1) on ET day (< 19 ng/ml) | -0.16 | 0.851 | (0.42–1.70) | 0.650 |
Progesterone value Q2 on ET day (19–29 ng/ml) | - | Reference group | - | - |
Progesterone value Q3 on ET day (29–49 ng/ml) | -0.65 | 0.51 | (0.25–1.06) | 0.073 |
Progesterone value Q4 on ET day (> 49 ng/ml) | -1.41 | 0.24 | (0.10–0.54) | 0.001 |
Estradiol value Q1 on ET day (< 411 pg/m) | - | Reference group | - | - |
Estradiol value Q2 on ET day (411–632 pg/ml) | 0.60 | 1.82 | (0.87–3.83) | 0.11 |
Estradiol value Q3 on ET day (632–905 pg/ml) | 0.33 | 1.39 | (0.65–2.96) | 0.38 |
Estradiol value Q4 on ET day (> 905 pg/ml) | -0.43 | 0.65 | (0.28–1.46) | 0.30 |